Healthy life expectancy at record low for women in most deprived areas
The Covid-19 pandemic, with its increased levels of mortality, is continuing to have an impact on life expectancy estimates, according to the Office for National Statistics (ONS) which published the figures.
Females born between 2020 and 2022 in the most deprived areas of England were likely to spend just 65.1% of their lives in good health, compared with 81.5% in the least deprived areas, the ONS found.
The estimate for the most deprived areas is the lowest since the time series began in 2013-15, when it stood at 66.3%.
For males born in 2020-22, the proportion of life expected to be spent in good health was 70.4% for those in the most deprived areas and 84.5% for those in the least deprived.
The figure for males in the most deprived parts of England is broadly unchanged on recent years.
The gap in healthy life expectancy between females born in the most and least deprived areas has widened from 19.6 years in 2013-15 to 20.2 years in 2020-22, while for males it has grown from 18.7 to 19.1.
Greg Ceely, ONS head of population health monitoring, said: 'The pandemic led to increased mortality, the impact of which is seen in our life expectancy estimates.
'However, not everyone was impacted equally.
'The biggest decline in life expectancy was seen in the most deprived areas.
'Healthy life expectancy also declined, and in England and Wales women in the most deprived areas were expected to spend the lowest proportion of life in 'good' health – the smallest since our records began.'
Figures for Wales cannot be compared directly with England, due to different systems of measuring deprivation.
But the proportion of life that females born in 2020-22 in the most deprived areas of Wales are likely to spend in good health, 61.5%, is the lowest since those estimates began in 2013-15.
The equivalent figure for women born in the least deprived areas is 80.7%.
For males in Wales, the proportions were 70.2% for the most deprived areas and 83.6% for the least deprived.
Although the latest estimates represent a drop compared with the pre-pandemic period, this does not mean a baby born between 2020 and 2022 will necessarily go on to live a less healthy life.
Improvements in mortality rates in the future would lead to increases in life expectancy estimates, the ONS noted.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Edinburgh Live
3 hours ago
- Edinburgh Live
Edinburgh man was 'spending £400 a month on takeaways' before going on Mounjaro
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info An Edinburgh man who decided it was time to put his health first admits he was spending around £400 a month on takeaways. Michael Monaghan, 40, had to shield during the pandemic and saw his weight go up. After gaining over three stone, and feeling 'everything else was failing', he made the decision to go on Mounjaro. The medication, which was created to treat diabetes, works by activating receptors to increase hormones in the body, producing more insulin when needed. It also reduces the amount of sugar produced by the liver and slows down food digestion. After starting Mounjaro, Michael has seen hundreds of supportive messages on his YouTube channel where he's been posting videos of his journey. After booking a trip to Florida, he's set his goal of reaching 18 stone by the time he goes - having dropped two stone since starting Mounjaro four weeks ago. Speaking to Edinburgh Live, Michael said: "The deciding factor was health. I was shielding during Covid and I gained a lot of weight. "I think it was 3.5 stone I gained, and then I kept putting on weight because I kept eating. What can I say, I enjoy food. And I basically just decided to start Mounjaro because everything else failed. I was waiting for weight management for a year and a half on the NHS, I couldn't believe it. (Image: Michael Monaghan) "England have started doing Mounjaro on the NHS but it's not up here yet, they haven't decided how that's going to happen. So I decided to pay for it privately out of my own pocket, I was spending £400 a month on takeaways. Just Eat, Uber Eats, whatever. "If I take that money and put it into the jag, which is about £140 a month, I'm actually saving money. So that really changed my mindset." While he's not a big fan of needles, Michael decided it was worth it. Knowing it was time, he felt he needed something to look forward to - which is where the Florida trip came in. He continued: "I was curious about it, and I'd heard about the success people had, but I don't really like injecting myself. After looking into it, I just decided I have to do this. "I have to try something, and I need something to look forward to. We booked a trip to Florida, so I've got a goal of 18 stone by the time we go. Sign up for Edinburgh Live newsletters for more headlines straight to your inbox "I'm a big Disney fan, I'm an annual pass holder for Paris. I love the rides, and if I don't lose weight then I won't be able to do them all - it's a target. "I've got asthma and sleep apnea, and I've been told if I lose a bit of weight I might be able to get rid of that. It was getting uncomfortable, and this was the time to make a change and that's exactly what we've done." Michael has received incredible support on his YouTube channel, with hundreds of comments that have motivated him on his journey. With the backing of his followers, he feels he 'can't stop now. ' He added: "Everybody has been so supportive, not one bad comment. I've had emails from people talking about their experiences on the same journey. "It's really motivating for me, makes me feel like I can't give up. People understand that it's not just a case of going on a diet, it's about willpower." While he had a rough start on Mounjaro, Michael feels he's had 'no side effects' since then. Admitting he does 'miss some foods', he's noticed his weight drop since he started. (Image: Michael Monaghan) He told us: "This medicine takes away my cravings, and I know it's working. The first three days were bad, I had to take some time off work as I couldn't get out of bed. "I had cramps and a lot of pain, but it just went away and I haven't had any side effects since. I've come down from 22 stone and four pounds to 20 stone and 13 pounds. "I'm still eating, drinking lots of water and I've cut out all sweets, chocolate, and stuff. I do miss some food, I was thinking about the new McDonald's burger the other day. "When I lose enough weight, I could probably eat it. But before, I was eating two McDonald's a day on a daily basis and then home for sweets and crisps before late-night snacking. "That's why I was gaining weight every year. But now, I don't feel as hungry, I'm not craving things. My face is starting to change, my body is starting to change and I'm more active and I've definitely got more energy. The change has been amazing." Join Edinburgh Live's Whatsapp Community here and get the latest news sent straight to your messages. "My portion sizes are about half of what they used to be. I'm going up from 2.5 to five mg dosage soon, so we'll see how that goes. I'm still eating what I'm eating, having the food I like, but everything is cut in half. I've stopped late night eating as well. "I'm so motivated now, though, because I've noticed changes in myself, and I've got all these people from the YouTube channel behind me." NHS Lothian is currently 'developing pathways' before a phased rollout of drugs, including Saxenda, Wegovy and Mounjaro. They added: "NHS Lothian have a short life working group currently developing the pathway and once agreed we can start a phased roll out. We are aware of recent news of the roll out of weight loss medication prescribing in GP practices. Please note this applies to NHS England only. "NHS Lothian is considering a phased roll out of these medicines for weight management in line with Scottish Government guidance. We are actively developing clinical pathways to ensure safe prescribing and monitoring. Updates will be shared once these clinical pathways have been agreed in NHS Lothian." You can follow Michael's journey with Mounjaro on his YouTube channel here.
Daily Mirror
19 hours ago
- Daily Mirror
Covid strain in the UK could cause new 'wave of infection'
The XFG strain of Covid, known as Stratus, has quickly become one of the most dominant variants in the UK. An expert has warned that a new variant of Covid could cause another 'wave of infection'. The XFG variants, which are also known as 'Stratus', have already become the most dominant variant in the UK. The most recent figures from the UK Health Security Agency (UKHSA) indicate that the XFG strain, known as Stratus, is swiftly proliferating across England, with the World Health Organisation (WHO) alerting to its "rapidly growing" presence worldwide. As of May, the Stratus variant constituted 10 per cent of Covid-19 cases in England. Presently, the XFG and its derivative, XFG.3, are responsible for approximately 40 per cent of infections, according to UKHSA statistics. In the period spanning May 26 to June 8, 28.9 per cent of cases were identified as the XFG. 3 variant, while 11.4 per cent were attributed to XFG. As reported by the Manchester Evening News, both belong to the Stratus family, with XFG being the original and XFG. 3 its offshoot. Dr Alex Allen, consultant epidemiologist at UKHSA, said: "It is normal for viruses to mutate and change over time. UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and COVID-19 surveillance reports. "Based on the available information so far, there is no evidence to suggest that the XFG and XFG.3 variants cause more severe disease than previous variants, or that the vaccines in current use will be less effective against them." This update follows closely on the heels of the WHO's disclosure of a new "more transmissible" variant named Nimbus, or NB. 1.8.1, which is also under observation. The latest figures indicate that the Nimbus strain of Covid is on a downward trend in the UK, now accounting for just 7.19 per cent of cases in England under classification NB. 1.8.1. The Stratus variant has surpassed Nimbus to become the most prevalent variant in England. Virologist Professor Lawrence Young of Warwick University revealed to MailOnline the worrying rise of the Stratus variant and its forms XFG and XFG. 3: "The increased competitiveness of XFG and XFG.3 is likely due to new spike mutations which make these variants more able to evade the immune response." He sounded an alarm over waning immunity among the public, as a result of declining uptake of the spring booster vaccination and receding Covid infection numbers recently. Prof Young warned: "This could lead to a new wave of infection but it's difficult to predict the extent of this wave." Expressing concerns about the behaviour of the Stratus variant to Cosmopolitan UK, Dr Kaywaan Khan, Harley Street GP and Founder of Hannah London Clinic, said: "Unlike other variants, Stratus has certain mutations in the spike protein which could help it evade antibodies developed from prior infections or vaccinations." Dr Khan described the Stratus strain as an offshoot of the Omicron variant, known for its high transmissibility and first detected in November 2021. As we look at the situation in May 2025, reports show that XFG constitutes roughly 25 per cent of the global Covid case count. Dr Khan remarked: "Despite this, it is important to mention that Stratus seems to be no worse than earlier Omicron variants in terms of illness, hospitalisations, or deaths." The World Health Organisation (WHO) has cautioned that the XFG strain is proliferating swiftly on a global scale. The organisation reported that cases surged within a month, from accounting for seven per cent of worldwide instances to reaching 23 per cent as of June 1. Nevertheless, WHO has evaluated the threat level of this variant as "low". It maintains that there is no current evidence indicating that XFG presents additional health risks relative to prior variants of the virus. Symptoms The most recent COVID-19 variants, frequently casually referred to as "Frankenstein" variants, usually present with symptoms akin to previous Omicron subvariants. Such symptoms commonly include upper respiratory tract problems such as fever, cough, sore throat, runny nose, and sneezing. Further symptoms like fatigue, headache, muscle pains, and decreased appetite are typically reported as well. It's worth mentioning that the once distinctive symptom of loss of smell or taste appears to be less prevalent with Omicron infections.
The Independent
a day ago
- The Independent
What is new ‘Stratus' Covid variant? Symptoms as cases grow in UK
A new strain of Covid, with a unique symptom, is circulating in the UK, accounting for a high proportion of cases in England. The new strain, called Stratus, has two variants, XFG and XFG.3, with XFG.3 accounting for 30 per cent of cases in the country. Unlike other strains, some experts have suggested the Stratus variant is known for its unique symptom of giving people a hoarse voice. Despite accounting for a large proportion of new cases, experts are not concerned over the spread, noting it is normal for viruses to mutate and change. 'It is normal for viruses to mutate and change over time,' Dr Alex Allen, consultant epidemiologist of UKHSA said, adding that it continues to monitor all strains of Covid in the UK. What is 'Stratus' XFG and XFG.3? The World Health Organisation has designated the XFG as a 'variant under monitoring' and has said the additional public health risk posed by XFG is evaluated as low at the global level. Globally, XFG was estimated to have the highest relative growth compared to other varients currently circluated, including the recent 'Nimbus' NB.1.8.1. Current data does not indicate that this variant leads to more severe illness or deaths than other variants in circulation, the organisation said. What are the symptoms? While evidence shows an increased proportion of XFG WHO has not observed any signs that it has an increase in severity. 'While there are reported increases in cases and hospitalisations in some of the [South-east Asia Region] countries, which has the highest proportion of XFG, there are no reports to suggest that the associated disease severity is higher as compared to other circulating variants, the WHO said. Dr Allen from the UKHSA also noted: 'Based on the available information so far, there is no evidence to suggest that the XFG and XFG.3 variants cause more severe disease than previous variants, or that the vaccines in current use will be less effective against them.' It comes as new Covid variants continue to spread throughout the country, with Nimbus giving people razor-blade like sore throats last month. Some experts have claimed Stratus can give patients a 'hoarse voice.' What are the risks around XFG? The WHO have designated XFG as a 'low risk' globally. It said: 'XFG is growing rapidly compared to co-circulating variants globally. However, XFG exhibits only marginal additional immune evasion over [other varient] LP.8.1. While there are reported increases in cases and hospitalizations in some of the [South-east Asia Region] countries, which has the highest proportion of XFG, there are no reports to suggest that the associated disease severity is higher as compared to other circulating variants. 'The available evidence on XFG does not suggest additional public health risks relative to the other currently circulating Omicron descendant lineages.' Do the Covid vaccines work against NB.1.8.1? Based on available evidence the WHO said the current approved Covid-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease. The organisation said the current data suggests the risk of vaccine evasion is low, however additional laboratory studies are needed to further assess the risk of antibody escape. However, some experts have warned Stratus could also evade immunity from jabs. 'Unlike other variants, Stratus has certain mutations in the spike protein which could help it evade antibodies developed from prior infections or vaccinations,' Dr Kaywaan Khan, Harley Street GP and founder of Hannah London Clinic told Cosmopolitan UK.
